Optometry - Journal of the American Optometric Association
Volume 80, Issue 10 , Pages 592-598 , October 2009

Macular pigment and healthy vision

References 

  1. Snodderly DM, Brown PK, Delori FC, et al. The macular pigment. I. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci. 1984;25(6):660–673
  2. Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984;25(6):674–685
  3. Williams DL. Oxidation, antioxidants and cataract formation: a literature review. Vet Ophthalmol. 2006;9(5):292–298
  4. Christen WG, Liu S, Glynn RJ, et al. Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study. Arch Ophthalmol. 2008;126(1):102–109
  5. Antioxidant status and neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Arch Ophthalmol. 1993;111(1):104–109
  6. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272(18):1413–1420
  7. Snellen EL, Verbeek AL, Van Den Hoogen GW, et al. Neovascular age-related macular degeneration and its relationship to antioxidant intake. Acta Ophthalmol Scand. 2002;80(4):368–371
  8. Beatty S, Nolan J, Kavanagh H, et al. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys. 2004;430(1):70–76
  9. Hammond BR, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38(9):1795–1801
  10. Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71(6):1555–1562
  11. Landrum JT, Bone RA, Kilburn MD. The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol. 1997;38:537–556
  12. Richer S, Stiles W, Statkute L, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75(4):216–230
  13. Stringham JM, Hammond B. Macular pigment and visual performance under glare conditions. Optom Vis Sci. 2008;85(2):82–88
  14. Aleman TS, Duncan JL, Bieber ML, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and usher syndrome. Invest Ophthalmol Vis Sci. 2001;42(8):1873–1881
  15. Berendschot TT, Goldbohm RA, Klopping WA, et al. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000;41(11):3322–3326
  16. Francois JL, Askew EW, Lang LC, Bernstein PS. Serum and macular response to antioxidant supplementation versus a carotenoid-rich dietary intervention in elderly. Curr Top Neutraceutical Res. 2006;4(1):69–78
  17. Bone RA, Landrum JT, Guerra LH, et al. Lutein and Zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133(4):992–998
  18. Bone RA. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metab. 2007;4(12):
  19. Cardinault N, Gorrand JM, Tyssandier V, et al. Short-term supplementation with lutein affects biomarkers of lutein status similarly in young and elderly subjects. Exp Gerontol. 2003;38(5):573–582
  20. Duncan JL, Aleman TS, Gardner LM, et al. Macular pigment and lutein supplementation in choroideremia. Exp Eye Res. 2002;74(3):371–381
  21. Francoise JL, Askew EW, Lang JC, et al. Serum and macular responses to antioxidant supplementation versus a carotenoid-rich dietary intervention in the elderly. Curr Topics Nutraceutical Res. 2006;4(1):69–78
  22. Johnson EJ, Chung HY, Caldarella SM, et al. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr. 2008;87(5):1521–1529
  23. Koh HH, Murray IJ, Nolan D, et al. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res. 2004;79(1):21–27
  24. Kopsell DA, Lefsrud MG, Kopsell DE, et al. Spinach cultigen variation for tissue carotenoid concentrations influences human serum carotenoid levels and macular pigment optical density following a 12-week dietary intervention. J Agric Food Chem. 2006;54(21):7998–8005
  25. Kvansakul J, Rodriguez-Carmona M, et al. Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance. Ophthalmic Physiol Opt. 2006;26(4):362–371
  26. Landrum JT, Bone RA, Joa H, et al. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res. 1997;65(1):57–62
  27. Landrum JT, Chen Y, Bone RA, et al. Serum and macular pigment response to 2.4 mg dosage of lutein (Abstract). ARVO. 2000;41(4):S60
  28. Morganti P, Fabrizi G, Bruno C. Protective effects of oral antioxidants on skin and eye function. Skinmed. 2004;3(6):310–316
  29. Richer S, Devenport J, Lang JC. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry. 2007;78(5):213–219
  30. Rodriguez-Carmona M, Kvansakul J, Harlow JA, et al. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and colour vision. Ophthalmic Physiol Opt. 2006;26(2):137–147
  31. Schalch W, Cohn W, Barker FM, et al. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin—the LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys. 2007;458(2):128–135
  32. Schweitzer D, Lang GE, Beuermann B, et al. Objektive bestimmung der optischen dichte von xanthophyll nach supplementation von lutein. Ophtalmologe. 2002;99:270–275
  33. Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res. 2007;84(4):718–728
  34. Wenzel AJ, Gerweck C, Barbato D, et al. A 12-wk egg intervention increases serum zeaxanthin and macular pigment optical density in women. J Nutr. 2006;136(10):2568–2573
  35. Wenzel AJ, Sheehan JP, Gerweck C, et al. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation. Ophthalm Physiol Optics. 2007;27(4):329–335
  36. Yolton D, DeRuyter B, Miller B, et al. Failure of oral supplement containing lutein to change macular pigment density. Abstract presented at the American Academy of Optometry Conference; December 12, 2002; San Diego, CA.
  37. Zeimer M, Hense HW, Heimes B, et al. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study]. Ophthalmologe. 2009;106(1):29–36
  38. The Relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol. 2007;125(9):1225–1232
  39. Bone RA, Landrum JT, Mayne ST, et al. Macular pigment in donor eyes with and without AMD: a case-control study. Invest Ophthalmol Vis Sci. 2001;42(1):235–240
  40. Neelam K, Hogg RE, Stevenson MR, et al. Carotenoids and co-antioxidants in age-related maculopathy: design and methods. Ophthalmic Epidemiol. 2008;15(6):389–401
  41. Bernstein PS, Zhao DY, Wintch SW, et al. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology. 2002;109(10):1780–1787
  42. Cho E, Seddon JM, Rosner B, et al. Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol. 2004;122(6):883–892
  43. Delcourt C, Carriere I, Delage M, et al. Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age-related maculopathy and cataract: the POLA Study. Invest Ophthalmol Vis Sci. 2006;47(6):2329–2335
  44. Gale CR, Hall NF, Phillips DI, et al. Lutein and zeaxanthin status and risk of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2003;44(6):2461–2465
  45. Moeller SM, Parekh N, Tinker L, et al. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2006;124(8):1151–1162
  46. Tan JS, Wang JJ, Flood V, et al. Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Ophthalmology. 2008;115(2):334–341
  47. Vu HT, Robman L, McCarty CA, et al. Does dietary lutein and zeaxanthin increase the risk of age related macular degeneration? The Melbourne Visual Impairment Project. Br J Ophthalmol. 2006;90(3):389–390
  48. Hammond BR, Curran-Celentano J, Judd S, et al. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res. 1996;36(13):2001–2012
  49. Hammond BR, Fuld K, Snodderly DM. Iris color and macular pigment optical density. Exp Eye Res. 1996;62(3):293–297
  50. Hammond BR, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res. 1996;36(18):3003–3009
  51. Bone RA, Sparrock JM. Comparison of macular pigment densities in human eyes. Vision Res. 1971;11(10):1057–1064
  52. Hammond BR, Fuld K. Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci. 1992;33(2):350–355
  53. Beatty S, Koh HH, Carden D, et al. Macular pigment optical density measurement: a novel compact instrument. Ophthalmic Physiol Opt. 2000;20(2):105–111
  54. Snodderly DM, Mares JA, Wooten BR, et al. Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study. Invest Ophthalmol Vis Sci. 2004;45(2):531–538
  55. Bernstein PS, Yoshida MD, Katz NB, et al. Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci. 1998;39(11):2003–2011
  56. Delori FC. Spectrophotometer for noninvasive measurement of intrinsic fluorescence and reflectance of the ocular fundus. Applied Optics. 1994;33:7439–7452
  57. Beatty S, Murray IJ, Henson DB, et al. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001;42(2):439–446
  58. LaRowe TL, Mares JA, Snodderly DM, et al. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative. Ophthalmology. 2008;115(5):876–877e1
  59. Obana A, Hiramitsu T, Gohto Y, et al. Macular carotenoid levels of normal subjects and age-related maculopathy patients in a Japanese population. Ophthalmology. 2008;115(1):147–157
  60. Ciulla TA. Hammond BR, Jr. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol. 2004;138(4):582–587
  61. Nolan JM, Stack J, O OD, et al. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res. 2007;84(1):61–74

PII: S1529-1839(09)00426-6

doi: 10.1016/j.optm.2009.08.002

Optometry - Journal of the American Optometric Association
Volume 80, Issue 10 , Pages 592-598 , October 2009

Article Tools